Skip to content

Orthostatic Hypotension in Rehabilitation Patients

Orthostatic Hypotension in Rehabilitation Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00117585
Enrollment
341
Registered
2005-07-07
Start date
2005-11-30
Completion date
2008-09-30
Last updated
2016-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension, Orthostatic

Keywords

Aging, Blood pressure, Hypotension, Orthostatic, Rehabilitation

Brief summary

The purpose of this study is to determine the prevalence and clinical course of orthostatic hypotension (OH) on a rehabilitation and nursing home unit during their inpatient stay and to initiate a standardized, interdisciplinary treatment plan for patients with OH and determine the effect of treatment on the clinical course of OH during their inpatient stay.

Detailed description

This study is a prospective, quasi-experiment conducted in two consecutive phases. During the observation phase, eligible patients are identified and followed through their usual course of care in the nursing home/rehabilitation unit. During the intervention phase, patients enrolled who have OH will receive the intervention. Patients will be enrolled over two research phases and the investigators expect to evaluate 459 subjects. This research program will occur over a three-year period. Methods: During Phase I, baseline prevalence and natural history of OH will be determined by: enrolling consecutive appropriate subjects (able to stand, not end of life care) from a rehabilitation and nursing home unit and measuring OH 3 times weekly over their inpatient stay. In addition, chart review of diagnoses, medications, functional status, nutrition, and adverse events will be evaluated and correlated with clinical status. During Phase II, the investigators will implement a standardized, interdisciplinary (MD/RN/PT/Dietician) treatment plan for patients with OH. This will include chart review of diagnoses, medications, functional status, nutrition, adverse events, and correlation with clinical status. The goals of the interventions are to identify and treat the underlying causes of OH in rehabilitation patients. Based upon the comprehensive assessment, intervention participants will receive a standardized, interdisciplinary treatment regime.

Interventions

OTHERTreatment Phase 1

* Patient Education * Physical Therapy Exercises * Increased Salt Intake * Elevation of head of bed with 2-4 inch wedge * Medication Review by MD, Pharma

DRUGTreatment Phase 2

Subjects receive Treatment Phase 2 if they are still orthostatic after receiving Treatment Phase 1. * Fludrocortisone * Salt tablet

OTHERTreatment Phase 3

Subjects still experiencing orthostatic hypotension after receiving Treatment Phases 1 and 2 move on to Treatment Phase 3. Individualized treatment is based on subspecialty or orthostatic hypotension consultation at the medical center. Subjects are followed for the duration of their hospital stay, on average 4 weeks.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to Vancouver VA Nursing Home or Rehabilitation ward

Exclusion criteria

* Unable to stand upon admission * Hospice admission * Respite admission

Design outcomes

Primary

MeasureTime frameDescription
Orthostatic Hypotension at DischargeLast three blood pressures prior to dischargeParticipants are assessed for orthostatic hypotension up to one time per day. The outcome measure is the last three days prior to discharge that blood pressures were assessed for orthostatic hypotension.

Countries

United States

Participant flow

Recruitment details

341 subjects were recruited. These subjects were recruited from all admits to the rehabilitation unit.

Pre-assignment details

Exclusion criteria included subjects who: couldn't stand, were admitted for respite, and were anticipated to only be on station for less than 7 days.

Participants by arm

ArmCount
Arm 1
Stepped intervention consisting of three treatment phases Treatment 1 : Patient Education Physical Therapy Exercises Increased Salt Intake Elevation of head of bed with 2-4 inch wedge Medication Review by MD, Pharmacist Treatment 2 : Fludrocortisone Salt tablets Treatment 3 : Individualized treatment based on subspecialty or orthostatic hypotension consultation at the medical center
341
Total341

Baseline characteristics

CharacteristicArm 1
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
341 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous75 years
STANDARD_DEVIATION 8
Region of Enrollment
United States
341 participants
Sex: Female, Male
Female
41 Participants
Sex: Female, Male
Male
300 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 341
serious
Total, serious adverse events
6 / 341

Outcome results

Primary

Orthostatic Hypotension at Discharge

Participants are assessed for orthostatic hypotension up to one time per day. The outcome measure is the last three days prior to discharge that blood pressures were assessed for orthostatic hypotension.

Time frame: Last three blood pressures prior to discharge

ArmMeasureValue (NUMBER)
Arm 1Orthostatic Hypotension at Discharge96 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026